Mercer Global Advisors Inc Lipocine Inc. Transaction History

Mercer Global Advisors Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$0.49 - $7.65 $73,500 - $1.15 Million	-150,000 Reduced 48.53%	159,111 $72,000
Q1 2022 May 10, 2022	SELL	$0.89 - $1.85 $3,560 - $7,400	-4,000 Reduced 1.28%	309,111 $423,000
Q3 2021 Nov 10, 2021	BUY	$1.08 - $1.49 $21,600 - $29,800	20,000 Added 6.82%	313,111 $341,000
Q2 2021 Aug 10, 2021	BUY	$1.17 - $1.59 $95,824 - $130,222	81,901 Added 38.78%	293,111 $410,000
Q1 2021 May 11, 2021	SELL	$1.38 - $2.28 $110,399 - $182,399	-80,000 Reduced 27.47%	211,210 $319,000
Q4 2020 Feb 12, 2021	BUY	$1.2 - $1.69 $60,000 - $84,500	50,000 Added 20.73%	291,210 $396,000
Q3 2020 Dec 10, 2020	SELL	$1.21 - $2.23 $37,266 - $68,681	-30,799 Reduced 11.32%	241,210 $340,000
Q2 2020 Aug 10, 2020	BUY	$0.42 - $1.26 $63,697 - $191,092	151,661 Added 126.02%	272,009 $343,000
Q1 2020 May 18, 2020	BUY	$0.32 - $0.77 $16,000 - $38,500	50,000 Added 71.08%	120,348 $58,000
Q4 2019 Feb 13, 2020	SELL	$0.32 - $3.15 $19,153 - $188,543	-59,855 Reduced 45.97%	70,348 $27,000
Q3 2019 Nov 12, 2019	SELL	$1.79 - $3.33 $71,600 - $133,200	-40,000 Reduced 23.5%	130,203 $365,000
Q2 2019 Aug 14, 2019	SELL	$1.43 - $2.32 $60,060 - $97,440	-42,000 Reduced 19.79%	170,203 $332,000
Q1 2019 Apr 23, 2019	BUY	$1.46 - $2.33 $22,374 - $35,707	15,325 Added 7.78%	212,203 $490,000
Q1 2019 Apr 12, 2019	BUY	$1.46 - $2.33 $287,441 - $458,725	196,878 New	196,878 $256,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $433M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.